• Kyodo

  • SHARE

Shimadzu Corp. will soon commercialize a blood test designed to detect early-stage colon cancer, which tends to go unnoticed until symptoms become apparent at a more advanced stage.

The precision equipment-maker introduced the new diagnostic method on a trial basis at a hospital in Kyoto in October and plans to launch a commercial screening service in 2019 with a goal of being able to offer it across the country in a few years.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)